Vaccines based on mutant CALR and JAK2 and their uses
Ricardo Attar, Lawrenceville, NJ (US); Jason Dehart, San Diego, CA (US); Selina Khan, Leiden (NL); Vinod Krishna, Philadelphia, PA (US); Jenifer Lum, Castro Valley, CA (US); Christian Maine, San Diego, CA (US); Barbara Sanders, Amsterdam (NL); Manuel Alejandro Sepulveda, West Windsor, NJ (US); Patrick Wilkinson, Collegeville, PA (US); and Roland Zahn, Rijnsburg (NL)
Assigned to Janssen Biotech, Inc., Horsham, PA (US)
Filed by Janssen Biotech, Inc., Horsham, PA (US)
Filed on Nov. 13, 2020, as Appl. No. 17/097,458.
Claims priority of provisional application 62/936,846, filed on Nov. 18, 2019.
Claims priority of provisional application 62/936,841, filed on Nov. 18, 2019.
Prior Publication US 2021/0222133 A1, Jul. 22, 2021